According to BeInCrypto, Moderna stock has risen sharply this year within the S&P 500, outperforming other companies focused on artificial intelligence. Full data for a cancer vaccine is scheduled to be released on October 24.
According to BeInCrypto, Moderna stock has risen sharply this year within the S&P 500, outperforming other companies focused on artificial intelligence. Full data for a cancer vaccine is scheduled to be released on October 24.
